Wnt signaling in cancer

Zhan, T, Rindtorff, N, Boutros, M·2017·Oncogene
DOI 10.1038/onc.2016.304

Cites (213)

Items 201–212 of 212

  1. Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
    Andy J. Chien, Lauren Elaine Haydu, Travis L. Biechele, Rima M. Kulikauskas, Helen Rizos, Richard F. Kefford, Richard A. Scolyer, Randall T. Moon, Georgina Venetia Long · 2014 · PLoS ONE
  2. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
    Evgeny A. Moskalev, Katrin Luckert, Ivan A. Vorobjev, Sergey Mastitsky, Aleena Gladkikh, Achim Stephan, Marita Schrenk, Kamil’ Daniyalovich Kaplanov, Olga Borisovna Kalashnikova, Oliver Poetz et al. · 2012 · BMC Cancer
  3. β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL
    Deepika Kaveri, Philippe Kastner, Doulaye Dembélé, Claus Nerlov, Susan H. Chan, Peggy Kirstetter · 2013 · Blood
  4. Wnt‐mediated protein stabilization ensures proper mitotic microtubule assembly and chromosome segregation
    Ailine Stolz, Kim Neufeld, Norman Ertych, Holger Bastians · 2015 · EMBO Reports
  5. A phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.
    Robert R. McWilliams, Andrew H. Ko, Elena Gabriela Chiorean, Eunice Lee Kwak, Heinz‐Josef Lenz, Paul I. Nadler, Debra L. Wood, Masamoto Fujimori, Kohei Morita, Tetsuhi Inada et al. · 2015 · Journal of Clinical Oncology
  6. Inverse correlation of the up‐regulation of FZD10 expression and the activation of β‐catenin in synchronous colorectal tumors
    Satoshi Nagayama, Eiji Yamada, Yoshiki Kohno, Tomoki Aoyama, Chikako Fukukawa, Hajime Kubo, Go Watanabe, Toyomasa Katagiri, Yusuke Nakamura, Yoshiharu Sakai et al. · 2009 · Cancer Science
  7. β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
    Joseph Rosenbluh, Deepak Nijhawan, Andrew Graham Cox, Xingnan Li, James T. Neal, Eric J. Schafer, Travis Ian Zack, Xiaoxing Wang, Aviad Tsherniak, Anna C. Schinzel et al. · 2013 · Cell
  8. Differentiation Generates Paracrine Cell Pairs That Maintain Basaloid Mouse Mammary Tumors: Proof of Concept
    Soyoung Kim, Shruti Goel, Caroline M. Alexander · 2011 · PLoS ONE
  9. Abstract 1907: Wnt pathway antagonist OMP-54F28 (FZD8-Fc) inhibits tumor growth and reduces tumor-initiating cell frequency in patient-derived hepatocellular carcinoma and ovarian cancer xenograft models
    Pete Yeung, Lucia Beviglia, Belinda Cancilla, Cristina Dee-Hoskins, James Evans, Marcus M. Fischer, Wan-Ching Yen, Austin L. Gurney, John A. Lewicki, Timothy C. Hoey et al. · 2014 · Cancer Research
  10. Sticking Around: Short-Range Activity of Wnt Ligands
    Michael Boutros, Christof Niehrs · 2016 · Developmental Cell
  11. Abstract A116: Targeting the Wnt-5a signaling pathway as a novel anti-metastatic therapy
    Tommy Andersson, Lena Axelsson, Purusottam Mohapatra, Chandra Prakash Prasad, Peter Grundtvig Soerensen, Morten Mau‐Sørensen, Ulrik Lassen, Tine Molvadgaard, Ulla Hald Buhl, Nils Brünner et al. · 2015 · Molecular Cancer Therapeutics
  12. Abstract A30: Predictive and pharmacodynamic biomarkers of vantictumab (OMP-18R5; anti-Frizzled) in non-small cell lung cancer
    CHUN ZHANG, Fiore Cattaruzza, Pete Yeung, Wan-Ching Yen, Marcus M. Fischer, Alayne L. Brunner, Min Wang, Belinda Cancilla, Rainer Karl Brachmann, Tim Hoey et al. · 2015 · Molecular Cancer Therapeutics